JPM 2016: Big Pharma Committed To Emerging Markets Despite Volatility
This article was originally published in PharmAsia News
What's in store in 2016 for big pharma in emerging markets amid increasing volatility in this sector? A number of top executives shared their views at the recent JP Morgan Healthcare Conference, and the overall message was one of continuing commitment and expansion and need for balance with the rest of the business.
Register for our free email digests: